Stock Comparison

ABBV vs IVVD

AbbVie Inc vs Invivyd Inc

The Verdict

IVVD takes this one.

ABBV

AbbVie Inc

0.1

out of 10

Distressed

Winner

IVVD

Invivyd Inc

7.5

out of 10

Solid Pick

Head-to-Head

$403.8B

Market Cap

$406M

171.8

P/E Ratio

-3.7

N/A

Profit Margin

-98.2%

N/A

Return on Equity

-67.9%

N/A

Debt-to-Equity

0.0

Moderate

Overall Risk

Aggressive

0.1

DVR Score

7.5

The Deep Dive

ABBV0.1/10

AbbVie Inc. (ABBV) is a well-established mega-cap pharmaceutical company with a robust product portfolio, strong financial health, and a leading position in key therapeutic areas. It excels as a stable dividend payer and a defensive holding. However, its fundamental characteristics, including its immense market capitalization ($397.29B), the mature nature of the pharmaceutical industry, high R&D c...

Full ABBV Analysis

IVVD7.5/10

Invivyd (IVVD) presents a compelling high-risk, high-reward opportunity, demonstrating significant improvement since our last analysis. The reported Q4 2025 earnings (March 5, 2026) were a major catalyst, showcasing a substantial revenue beat ($17.2M actual vs. $15.77M est.), a 31% sequential growth for PEMGARDA, and a remarkable 110% YoY revenue increase for FY 2025 to $53.4M. Critically, Q4 2025...

Full IVVD Analysis

Want More Comparisons?

Run any stock through our deep value analyzer.

Analyze Any Stock →

Not Financial Advice

This comparison is for educational purposes only. We are not financial advisors. Always do your own research and consult a qualified advisor before investing.